Skip to main content

ASCENT™

A shift in aspiration philosophy

Take precision into your hands with a single point of control.

Experience ASCENT™ first-hand

Schedule a Demo

Engineered to meet the full needs of neurointerventionists

Fine-tunes control by combining access, aspiration, and support under a single, custom system.

ASCENT approach: Mono-axial

ASCENT approach

Traditional approach: Multi-axial

Traditional approach

ASCENT™ eliminates:

Device stacking icon

Device stacking

Procedural fragmentation icon

Procedural fragmentation

Multiple points of control and complexity

Multiple points of control and complexity

The Clinical Rise of ASCENT™

  1. May 2025

    Top three enrolling SUMMIT MAX sites confirm ASCENT™ technique†

  2. Jan 2026

    Passive advancement data initially presented at Val d’Isère—clot ingestion without crossing, a cornerstone of ASCENT™§

  3. Feb 2026

    Dr. Dan Tonetti names ASCENT™ from the podium at LINNC Online—its formal entry into the clinical lexicon‖

  4. June 2026

    Tenzing-powered delivery with vacuum-effect delivery established as a procedural approach in aspiration thrombectomy‡

  5. July 2026

    Vacuum experience presented at SNIS, reinforcing ASCENT™ as a reproducible first-pass technique

†SUMMIT MAX substudy poster, ESOC 2025.

§Val d’Isère presentation, January 2026.

‖Tonetti D. LINNC Online, February 2026.

‡Clark WE, et al. Oper Neurosurg. Published online June 18, 2026. doi:10.1227/ONS.0000000000002109

Alexander D, et al. SNIS Annual Meeting, 2026.

Full-Caliber Aspiration Built for End-to-End Performance

Rendering of the ASCENT catheter engaging a clot within a vessel
  • Optimizes aspiration
  • Reliably delivers to the clot
  • Improves ingestion and revascularization
  • Maximizes clot engagement with vessel-matched aspiration

ASCENT™ utilizes Tenzing-enabled navigation and positioning.

“This is an evolution in catheter technology. HiPoint, Base Camp, and Tenzing is a beautiful example of that evolution. You don’t need a “tower of power.” You’re getting an .088″ to the M1 with single-catheter support. This is way more dynamic than 3 catheters not made to fit inside each other. This is a tremendous advantage of the technology working in the best interest of the patient.”

— Ricardo Hanel, MD, PhD

One System. One Approach. One Flow.

Aspiration, access, and support integrated into one seamless platform. Enables rapid controlled intervention when every second matters.

HiPoint 88 Reperfusion System HiPoint 88 Reperfusion System HiPoint 88 Reperfusion System HiPoint 88 Reperfusion System

Introducing the HiPoint® 88 Reperfusion System

Tenzing® Delivery Catheter

  • For smooth, atraumatic advancement through the primary vessel

HiPoint® 88 Reperfusion System

  • Single point of control with the Monopoint® Zone
  • Vessel-matched to ICA-T and M1
  • Optimizes suction force at the clot face
  • Reduces catheter friction

Base Camp

  • Base Camp® sheath system 2.0 has a stainless-steel compact pitch coil that provides high structural stability, while the dual-layer strain relief reinforces the hub for proximal support during advancement
HiPoint 88 Reperfusion System

FreeClimb® 70 Reperfusion System

  • Bi-axial platform
  • Optimizes suction force at the clot face*
  • No additional support or anchoring devices required

Outstanding Results from SUMMIT MAX including Top 3 Enrolling Sites

Highest recorded First Pass Effect (FPE) in stroke randomized clinical trials1

96% successful delivery to the M12

96% of cases performed with ASCENT required no adjunctive devices2

0% incidence of sICH2

1Nguyen TH, et al. Stroke. 2025;56(8):19801990. doi.org/10.1161/STROKEAHA.125.05174 (SUMMIT MAX; ESOC, Helsinki, May 2123, 2025)

2Caldwell J, Priest R, Boo S, et al. Sub-analysis of SUMMIT MAX shows correlation between FPE and operator enrollment volume with the HiPoint 88/70 system. Presented at: 11th European Stroke Organisation Conference –ESOC 2025. 2025.

Significant Cost Savings

  • 22% lower device spend with HiPoint® vs. contact aspiration and 59% lower vs. stentriever aspiration
  • 57% lower total hospital cost vs. stentriever-aspiration
  • HiPoint® achieved target reperfusion with fewer passes, savings of ~$1,300 direct cost per pass
View Publication

Explore More

Angiographic case video one

Tortuous ICA navigation to the M1 using 8F Base Camp sheath, HiPoint 88 Reperfusion System with Tenzing 8

Angiographic case video two

M1 occlusion treated with HiPoint 88 Reperfusion System and Tenzing 8

Angiographic case video three

M2 Occlusion treated with FreeClimb 54 Reperfusion System and Tenzing 5

Safety Information

Caution

Federal (USA) law restricts these devices to sale by or on the order of a physician. Prior to use, please refer to the Instructions for Use for complete product indications, contraindications, warnings, precautions, potential adverse events, and detailed instructions for use. Images used with permission. Please review https://www.route92medical.com/safety-information for important risk information.